Why Do I Need An Advisor? The bottom line is that selling a company is very challenging. If you haven’t been through an M&A process there tends to be this misconception that it is like selling real estate. There is so much to it, on top of the fact that you have to continue to run your business.
Andre Ulloa, Partner and Executive Advisor at M&A Healthcare Advisors, shares part 2 of our 2022 transactional outlook covering four main Pharmacy segments: Specialty, Community Retail, Long Term Care, and Infusion.
Andre Ulloa, partner with M&A Healthcare Advisors, told McKnight’s Home Care Daily Pulse in an email that Enhabit could be an attractive acquisition target for Aveanna. He said the home health and hospice company has been growing organically and has made no secret that it wants to accelerate growth through acquisitions.
Mike Moran, Co-Founder and Executive Advisor at M&A Healthcare Advisors, shares part 1 of our 2022 transactional outlook covering the Home Health, Home Care, Hospice, and Behavioral Health segments.
“Join us at the Home Health Summit to learn steps you can take to maximize the valuation of your healthcare business.” – Andre Ulloa, Partner & Executive Advisor, M&A Healthcare Advisors.
